Literature DB >> 3417303

Tight linkage between myotonic dystrophy and apolipoprotein E genes revealed with allele-specific oligonucleotides.

B Smeets1, J Poddighe, H Brunner, H H Ropers, B Wieringa.   

Abstract

In 16 families with myotonic dystrophy (DM) a novel approach based on use of allele-specific oligonucleotides has been employed to study the linkage relationship between the apolipoprotein E (APOE) gene and DM. Synthetic oligonucleotides, designed to discriminate between APOE alleles epsilon 3 and epsilon 4, enabled us to distinguish heterozygous carriers in a hybridization assay. In a subset of families, the relevant segment of the APOE gene was enzymatically amplified to increase the sensitivity of the method. For DM and APOE, a maximum lod score (zmax of 7.47 was obtained at a recombination frequency (theta) of 0.047 (male theta = female theta). No recombination (maximum lod score of 5.61 at theta = 0.0) was found between APOE and the apolipoprotein CII (APOC2) gene. These results suggest that, in addition to APOC2, APOE is a useful marker for presymptomatic DM diagnosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3417303     DOI: 10.1007/BF00451455

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  30 in total

1.  Report of the committee for chromosomes 17, 18, and 19.

Authors:  D Shaw; H Eiberg
Journal:  Cytogenet Cell Genet       Date:  1987

2.  Report of the Committee on the Genetic Constitution of Chromosomes 17, 18 and 19.

Authors:  S Naylor; J M Lalouel; D J Shaw
Journal:  Cytogenet Cell Genet       Date:  1985

Review 3.  Human apolipoprotein molecular biology and genetic variation.

Authors:  J L Breslow
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  Rapid prenatal diagnosis of sickle cell anemia by a new method of DNA analysis.

Authors:  S H Embury; S J Scharf; R K Saiki; M A Gholson; M Golbus; N Arnheim; H A Erlich
Journal:  N Engl J Med       Date:  1987-03-12       Impact factor: 91.245

5.  A strategy to reveal high-frequency RFLPs along the human X chromosome.

Authors:  J Aldridge; L Kunkel; G Bruns; U Tantravahi; M Lalande; T Brewster; E Moreau; M Wilson; W Bromley; T Roderick
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

6.  Tight linkage of apolipoprotein C2 to myotonic dystrophy on chromosome 19.

Authors:  M A Pericak-Vance; L H Yamaoka; R I Assinder; W Y Hung; R J Bartlett; J M Stajich; P C Gaskell; D A Ross; S Sherman; G H Fey
Journal:  Neurology       Date:  1986-11       Impact factor: 9.910

7.  The locus for apolipoprotein CII is closely linked to the apolipoprotein E locus on chromosome 19 in man.

Authors:  O Myklebost; S Rogne; B Olaisen; T Gedde-Dahl; H Prydz
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  A DNA polymorphism adjacent to the human apolipoprotein CII gene.

Authors:  S E Humphries; N I Jowett; L Williams; A Rees; M Vella; A Kessling; O Myklebost; A Lydon; M Seed; D J Galton
Journal:  Mol Biol Med       Date:  1983-12

9.  Application of a closely linked polymorphism of restriction fragment length to counselling and prenatal testing in families with myotonic dystrophy.

Authors:  A L Meredith; S M Huson; P W Lunt; M Sarfarazi; H G Harley; J D Brook; D J Shaw; P S Harper
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-22

10.  Identification and DNA sequence of a human apolipoprotein E cDNA clone.

Authors:  J L Breslow; J McPherson; A L Nussbaum; H W Williams; F Lofquist-Kahl; S K Karathanasis; V I Zannis
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

View more
  2 in total

1.  Use of variable simple sequence motifs as genetic markers: application to study of myotonic dystrophy.

Authors:  H J Smeets; H G Brunner; H H Ropers; B Wieringa
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

2.  Rapid and safe determination of human apolipoprotein E genotypes by miniaturised SDS-PAGE in non-insulin dependent diabetes mellitus.

Authors:  C Clavel; A Durlach; V Durlach; P Birembaut
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.